Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
07/23/2013 | US8492542 Method for producing bicyclic guanidines by use of a cyclic thiourea |
07/23/2013 | US8492393 Heterobicyclic carboxamides as inhibitors for kinases |
07/23/2013 | US8492389 Inhibitors of human phosphatidylinositol 3-kinase delta |
07/23/2013 | US8492376 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
07/23/2013 | US8492374 Azaazulene compounds |
07/18/2013 | WO2013106792A1 Heterocyclic compounds and uses as anticancer agents. |
07/18/2013 | WO2013106728A1 Agents that prevent or repair skin damage |
07/18/2013 | WO2013106614A1 Triazolyl-substituted pyridyl compounds useful as kinase inhibitors |
07/18/2013 | WO2013106612A1 Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors |
07/18/2013 | WO2013105057A1 Fused pyrroles as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders |
07/18/2013 | WO2013104830A1 Novel heteroarylamide derivatives having antiandrogenic properties |
07/18/2013 | WO2013104611A1 Substituted pyrazolopyrimidines as akt kinase inhibitors |
07/18/2013 | WO2013104610A1 Substituted imidazopyrazines as akt kinase inhibitors |
07/18/2013 | WO2013104598A2 Substituted, annulated imidazoles and pyrazoles, and use thereof |
07/18/2013 | US20130184307 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
07/18/2013 | US20130184285 Pyrrolopyrimidine compounds and their uses |
07/18/2013 | US20130184282 Ip receptor agonist heterocyclic compounds |
07/18/2013 | US20130184274 Protein Kinase Inhibitors and Methods of Treatment |
07/18/2013 | US20130184273 Bicyclic pyrimidines |
07/18/2013 | US20130184271 Methods for Treating Parkinson's Disease Using Pro-Neurogenic Compounds |
07/18/2013 | US20130184259 Pyridones useful as inhibitors of kinases |
07/18/2013 | US20130184256 New substituted glycinamides, process for their manufacture and use thereof as medicaments |
07/18/2013 | US20130184240 Hetero ring-fused imidazole derivative having ampk activating effect |
07/18/2013 | US20130180589 Organic photovoltaic cell materials and components |
07/18/2013 | CA2860847A1 Substituted, annulated imidazoles and pyrazoles, and use thereof |
07/17/2013 | EP2615096A1 Quinoxaline compound |
07/17/2013 | EP2615091A2 Solid forms comprising 4-[9-(3S)-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-ylamino]-trans-cyclohexan-1-ol, compositions thereof, and uses therewith |
07/17/2013 | EP2615090A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors |
07/17/2013 | EP2615088A1 Composition, synthesis and use of new substituted pyran and pterin compounds |
07/17/2013 | EP2615087A2 Phenylalanine derivatives |
07/17/2013 | EP2614684A1 Broadly absorbing metalloporphyrin-based multichromophoric arrays for triplet harvesting |
07/17/2013 | EP2614067A2 Conductive open frameworks |
07/17/2013 | EP2614065A1 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors |
07/17/2013 | EP2614064A1 Inhibitors of human immunodeficiency virus replication |
07/17/2013 | EP2614063A1 Substituted imidazopyridazines |
07/17/2013 | EP2614062A1 Imidazo [1, 2]pyridazin compounds and compositions as trk inhibitors |
07/17/2013 | CN1771298B Fluorescent diketopyrrolopyrroles |
07/17/2013 | CN1660033B Composition for dyeing keratinous fibers comprising at least one diamino-n,n-dihydropyrazolone derivative |
07/17/2013 | CN103209982A Novel compound of a reverse-turn mimetic and a production method and use therefor |
07/17/2013 | CN103209963A 2-quinolinyl-acetic acid derivatives as HIV antiviral compounds |
07/17/2013 | CN103204858A Novel chirality antianxiety medicine prepared on basis of tartaric acid resolution and composition technique |
07/17/2013 | CN103204857A Synthesis method of 4-chlorine-2-(methylmercapto)-7H-pyrrolo [2, 3-D] pyrimidine |
07/17/2013 | CN103204856A Deuterated alprazolam and preparation method thereof |
07/17/2013 | CN103204855A Compound I tetrazole (1, 5-a) pyrimidine-5, 7-diol and synthetic route thereof |
07/17/2013 | CN103204854A Tetranitroglycoluril preparation method |
07/17/2013 | CN103204851A Benzamide derivative containing fused heterocyclic group and therapeutic use thereof |
07/17/2013 | CN103204846A Carbazole derivative, organic electroluminescent device thereof, and manufacturing method of device |
07/17/2013 | CN103204815A 4-(4-cyano-2-thioaryl)dihydropyrimidinones And Use Thereof |
07/17/2013 | CN102659815B Method for preparing selective anticoagulant ticagrelor and intermediates thereof |
07/17/2013 | CN102295647B All-alkyl substituted triindenyl cyclopi trimeric-indole derivative and preparation method thereof |
07/17/2013 | CN102153606B Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof |
07/17/2013 | CN101553489B 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, methods for their preparation and their use as antiviral agents |
07/17/2013 | CN101434605B Heterocyclic compound and an organic light emitting device comprising the same |
07/17/2013 | CN101248050B Organic compounds |
07/17/2013 | CN101203495B Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase MET |
07/16/2013 | US8487099 Gamma secretase modulators |
07/16/2013 | US8487098 Synergistic combination of flumetsulam or diclosulam with isothiazolones |
07/16/2013 | US8487096 Imidazo[1,2-B][1,2,4]triazines as C-MET inhibitors |
07/16/2013 | US8486989 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
07/16/2013 | US8486979 Analgesics; central nervous system disorders; attentiondeficit disorders;cognition activators; bipolar disorders; Alzheimer's disease; Down's syndrome; brain disorders |
07/16/2013 | US8486954 Heterobicyclic carboxamides as inhibitors for kinases |
07/16/2013 | US8486945 Heterocyclic inhibitors of an Hh-signal cascade, medicinal compositions based thereon and methods for treating diseases caused by the aberrant activity of an Hh-signal system |
07/16/2013 | US8486938 Pyrazolo[1,5-a]pyrimidines for antiviral treatment |
07/16/2013 | US8486928 Super-oxide dismutase mimetics |
07/16/2013 | US8486902 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
07/11/2013 | WO2013102929A1 Novel compounds for treatment of diabetes, obesity or related disorders |
07/11/2013 | WO2013102242A1 Heterocyclic compounds and methods for their use |
07/11/2013 | WO2013066458A3 Fluorescent sensing of vapors using tubular nanofibril materials |
07/11/2013 | WO2013049352A3 Anti-viral compounds |
07/11/2013 | WO2013039785A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
07/11/2013 | WO2012174379A3 Polyhedral cage-containing metalloporphyrin frameworks, methods of making, and methods of using |
07/11/2013 | US20130178623 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines |
07/11/2013 | US20130178622 Methods and Compositions for Treating Cancer |
07/11/2013 | US20130178618 Novel pharmaceutical intermediates and methods for preparing the same |
07/11/2013 | US20130178500 HEXAHYDROPYRROLO[3,4-b]PYRROLE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF |
07/11/2013 | US20130178486 Serine/threonine kinase inhibitors |
07/11/2013 | US20130178483 Methods and Compositions for Inhibition of Bone Resorption |
07/11/2013 | US20130178461 Inhibitors of bruton's tyrosine kinase |
07/11/2013 | US20130178458 Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine m1 receptors |
07/11/2013 | DE102012200357A1 New fluoroalkyl-substituted pyrazolopyridine compounds are soluble guanylate cyclase stimulators, useful to treat e.g. heart disease, angina pectoris, hypertension, pulmonary hypertension, ischemia, vascular disease or renal insufficiency |
07/11/2013 | DE102012200356A1 New substituted imidazopyrid(az)ine compounds are soluble guanylate cyclase stimulators, useful to treat e.g. heart disease, angina pectoris, hypertension, pulmonary hypertension, ischemia, vascular disease or renal insufficiency |
07/11/2013 | DE102012200352A1 Substituierte, annellierte Imidazole und Pyrazole und ihre Verwendung Substituted fused imidazoles and pyrazoles and their use |
07/11/2013 | DE102012200351A1 New substituted annellated pyrimidine compounds are guanylate cyclase stimulators useful to treat and/or prevent heart failure, hypertension, ischemia, vascular disease, renal failure, thromboembolic disorders and fibrotic diseases |
07/10/2013 | EP2612862A2 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
07/10/2013 | EP2612860A1 Quinazoline derivatives substituted by aniline, preparation method and use thereof |
07/10/2013 | EP2611810A1 Substituted tetrahydropyrrolopyrazine derivatives |
07/10/2013 | EP2611809A1 Azolopyridine and azolopyrimidine compounds and methods of use thereof |
07/10/2013 | EP2611808A1 Pyrazolopyridinone derivatives as lpa receptor antagonists |
07/10/2013 | EP2611802A1 Bicyclic aza heterocycles, and use thereof |
07/10/2013 | EP2611798A1 Pyridazinones, method of making, and method of use thereof |
07/10/2013 | EP2611790A1 Pyridinones/pyrazinones, method of making, and method of use thereof |
07/10/2013 | CN103201277A Pyridazinones, method of making, and method of use thereof |
07/10/2013 | CN103201274A Pyrrolidine derivatives used as cathepsin inhibitors |
07/10/2013 | CN103193786A Water-soluble fullerene-tetra(p-hydroxy phenyl) porphyrin as well as preparation method and application thereof |
07/10/2013 | CN103193785A Graphene-like C3N4 material, as well as preparation method and use thereof |
07/10/2013 | CN103193784A Pyrimidine group-containing rigid conjugated macrocyclic compound, as well as preparation method and application thereof |
07/10/2013 | CN103193783A Method for preparing hemin from yak blood powder as raw material |
07/10/2013 | CN103193782A Photosensitizer sodium chlorophyllin derivatives and their preparation method and use |
07/10/2013 | CN103193781A Specific inhibition compound of SAHN enzyme protein and synthetic method of specific inhibition compound |
07/10/2013 | CN103193780A Use of 4,7-dihydrotetrazyl[1,5-alpha]pyrimidine compound and its derivatives in preparation of drug for prevention or treatment on cerebral hemorrhage |